BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 31233143)

  • 21. Screening MRI in Women With a Personal History of Breast Cancer.
    Lehman CD; Lee JM; DeMartini WB; Hippe DS; Rendi MH; Kalish G; Porter P; Gralow J; Partridge SC
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26744477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in
    Guindalini RSC; Zheng Y; Abe H; Whitaker K; Yoshimatsu TF; Walsh T; Schacht D; Kulkarni K; Sheth D; Verp MS; Bradbury AR; Churpek J; Obeid E; Mueller J; Khramtsova G; Liu F; Raoul A; Cao H; Romero IL; Hong S; Livingston R; Jaskowiak N; Wang X; Debiasi M; Pritchard CC; King MC; Karczmar G; Newstead GM; Huo D; Olopade OI
    Clin Cancer Res; 2019 Mar; 25(6):1786-1794. PubMed ID: 30154229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.
    Berg WA; Zhang Z; Lehrer D; Jong RA; Pisano ED; Barr RG; Böhm-Vélez M; Mahoney MC; Evans WP; Larsen LH; Morton MJ; Mendelson EB; Farria DM; Cormack JB; Marques HS; Adams A; Yeh NM; Gabrielli G;
    JAMA; 2012 Apr; 307(13):1394-404. PubMed ID: 22474203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program.
    Eisen A; Blackmore KM; Meschino WS; Muradali D; Carroll JC; Majpruz V; Warner E; Rabeneck L; Chiarelli AM
    Mol Genet Genomic Med; 2018 Mar; 6(2):213-223. PubMed ID: 29368425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer.
    Lord SJ; Lei W; Craft P; Cawson JN; Morris I; Walleser S; Griffiths A; Parker S; Houssami N
    Eur J Cancer; 2007 Sep; 43(13):1905-17. PubMed ID: 17681781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Adjunctive Ultrasonography for Breast Cancer Detection Among Women Aged 40-49 Years With Varying Breast Density Undergoing Screening Mammography: A Secondary Analysis of a Randomized Clinical Trial.
    Harada-Shoji N; Suzuki A; Ishida T; Zheng YF; Narikawa-Shiono Y; Sato-Tadano A; Ohta R; Ohuchi N
    JAMA Netw Open; 2021 Aug; 4(8):e2121505. PubMed ID: 34406400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
    Mango VL; Goel A; Mema E; Kwak E; Ha R
    J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should we screen BRCA1 mutation carriers only with MRI? A multicenter study.
    Obdeijn IM; Winter-Warnars GA; Mann RM; Hooning MJ; Hunink MG; Tilanus-Linthorst MM
    Breast Cancer Res Treat; 2014 Apr; 144(3):577-82. PubMed ID: 24567197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
    Warner E; Plewes DB; Hill KA; Causer PA; Zubovits JT; Jong RA; Cutrara MR; DeBoer G; Yaffe MJ; Messner SJ; Meschino WS; Piron CA; Narod SA
    JAMA; 2004 Sep; 292(11):1317-25. PubMed ID: 15367553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of breast cancer screening using digital breast tomosynthesis: results from the prospective population-based Oslo Tomosynthesis Screening Trial.
    Skaane P; Sebuødegård S; Bandos AI; Gur D; Østerås BH; Gullien R; Hofvind S
    Breast Cancer Res Treat; 2018 Jun; 169(3):489-496. PubMed ID: 29429017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma.
    Ng AK; Garber JE; Diller LR; Birdwell RL; Feng Y; Neuberg DS; Silver B; Fisher DC; Marcus KJ; Mauch PM
    J Clin Oncol; 2013 Jun; 31(18):2282-8. PubMed ID: 23610104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of screening CEDM and MRI for women at increased risk for breast cancer: A pilot study.
    Jochelson MS; Pinker K; Dershaw DD; Hughes M; Gibbons GF; Rahbar K; Robson ME; Mangino DA; Goldman D; Moskowitz CS; Morris EA; Sung JS
    Eur J Radiol; 2017 Dec; 97():37-43. PubMed ID: 29153365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
    Lehman CD; Blume JD; Weatherall P; Thickman D; Hylton N; Warner E; Pisano E; Schnitt SJ; Gatsonis C; Schnall M; DeAngelis GA; Stomper P; Rosen EL; O'Loughlin M; Harms S; Bluemke DA;
    Cancer; 2005 May; 103(9):1898-905. PubMed ID: 15800894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.
    Warner E; Messersmith H; Causer P; Eisen A; Shumak R; Plewes D
    Ann Intern Med; 2008 May; 148(9):671-9. PubMed ID: 18458280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
    Leach MO; Boggis CR; Dixon AK; Easton DF; Eeles RA; Evans DG; Gilbert FJ; Griebsch I; Hoff RJ; Kessar P; Lakhani SR; Moss SM; Nerurkar A; Padhani AR; Pointon LJ; Thompson D; Warren RM;
    Lancet; 2005 May 21-27; 365(9473):1769-78. PubMed ID: 15910949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis.
    Phi XA; Houssami N; Hooning MJ; Riedl CC; Leach MO; Sardanelli F; Warner E; Trop I; Saadatmand S; Tilanus-Linthorst MMA; Helbich TH; van den Heuvel ER; de Koning HJ; Obdeijn IM; de Bock GH
    Eur J Cancer; 2017 Nov; 85():31-38. PubMed ID: 28886475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging.
    Lo G; Scaranelo AM; Aboras H; Ghai S; Kulkarni S; Fleming R; Bukhanov K; Crystal P
    Radiology; 2017 Oct; 285(1):36-43. PubMed ID: 28586291
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.